Postponement of APASL STC Osaka

Dear Colleagues and Friends,

Although we had planned to hold the APASL STC 2020 in Osaka, we regret to announce that the organizer of the APASL STC Osaka has decided to postpone the conference until September 2nd-3rd of 2021.

The current pandemic of COVID-19 is causing health and economic problems in many countries across the world and it seems that this situation will continue for the foreseeable future.


Norifumi Kawada, MD., PhD.
President of APASL STC 2021 Osaka

Welcome Message

Norifumi Kawada, MD., PhD
Norifumi Kawada, MD., PhD.
President of APASL STC 2021 Osaka
Professor, Department of Hepatology, Graduate School of Medicine,
Osaka City University

Dear colleagues,

On behalf of the Organizing Committee, it gives us great pleasure to invite you to Asian Pacific Association for the Study of the Liver Single Topic Conference (APASL STC) on the theme of "Molecular and Cell Biology of the Liver: Recent Evolution to Clinical Application", which will be held on September 2-3, 2021 in Osaka, Japan as a Hybrid Meeting (Zoom). (This conference had been originally scheduled in September 2020, however it has been rescheduled because of the pandemic of COVID-19. We ask your understanding and cooperation.) Chronic inflammation, cellular damage, regeneration and fibrosis are the hallmarks of chronic liver diseases. A recognition of molecular expression patterns in intrahepatic cellular sources in normal and diseased liver provides clues for understanding pathogenic pathways while studies of the structure and function of molecules implicated in liver disease provide insights into their potential as therapeutic targets.

This conference will bring together fundamental researchers and translational scientists to discuss recent successes and highlight challenges across the spectrum of emerging cellular and molecular evolutions. This conference will help to foster interactions and new connections between basic experts focused on molecular-based, cell-based regulation of liver diseases with translational scientists focused on therapeutic approaches currently in development.

The scientific program will consist of invited lectures, plenary sessions, symposia, and free papers which provide the latest information and fresh ideas for hepatologists. The delegates of experts from all over the world are expected to attend this conference. We are sure that this will provide an excellent opportunity for those of us in the Asian Pacific region to share the latest views, values, experience and practice, and greatly contribute to this field.

We look forward to welcoming you to this exciting event, and hopefully, if the situation allows, we hope you will be able to visit our charming city of Osaka.

With warmest regards,